The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer
Chiara Lucchetti(Temple University), Flavio Rizzolio(Ca' Foscari University of Venice)
Cited by 31
Related Papers
Carbon dots for cancer nanomedicine: a bright future
|Nanoscale Advances|2021|88
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1
|Cell Death and Differentiation|2012|76
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer
|Journal of Controlled Release|2018|46
Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy
|Journal of Materials Chemistry B|2023|32